Zacks Investment Research
06 Aug 2026, 17:46 UTC · 2h ago
Here is Why Growth Investors Should Buy Idexx (IDXX) Now
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
06 Aug 2026, 17:46 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Idexx Laboratories (IDXX) is projected to have EPS growth of 12.6% this year, exceeding the industry average of 10.8%. — Outperforming industry earnings growth expectations is a positive fundamental signal for the specific stock.
+0.30Idexx Laboratories currently holds a top Zacks Rank and a favorable Growth Style Score. — High ratings from a recognized research system typically correlate with positive investor sentiment and short-term price momentum.
+0.20Which stocks this story touches
The company is highlighted as a great growth pick with a top Zacks Rank and projected EPS growth that beats the industry average.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
5h ago
